<List><item><source>MED</source><extId>21559328</extId><pmcid>PMC3086880</pmcid><annotations><annotation><prefix> 2 proteins (ANPRA [</prefix><exact>P16066</exact><postfix>] and CASK [O14936])</postfix><tags><tag><name>P16066</name><uri>http://identifiers.org/uniprot/P16066</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-60f489c6da357ebd26a6aca190da5fe4</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix> [P16066] and CASK [</prefix><exact>O14936</exact><postfix>]) that have all 4 k</postfix><tags><tag><name>O14936</name><uri>http://identifiers.org/uniprot/O14936</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-e7ab3bb2fe42babdaf3ca478d94f2f58</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix>drug targets (ABL2 [</prefix><exact>P42684</exact><postfix>], UGDH [O60701], an</postfix><tags><tag><name>P42684</name><uri>http://identifiers.org/uniprot/P42684</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-e90bb2adbc7375572d6566f7627b26d7</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix>BL2 [P42684], UGDH [</prefix><exact>O60701</exact><postfix>], and NDST1 [P52848</postfix><tags><tag><name>O60701</name><uri>http://identifiers.org/uniprot/O60701</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-abecabef09ba95a8e741149a049fe125</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix>UGDH [O60701], and NDST1 [</prefix><exact>P52848</exact><postfix>]) (Fig. 6b). </postfix><tags><tag><name>P52848</name><uri>http://identifiers.org/uniprot/P52848</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-0d4dac9c7c10a073d75bbb8487869e64</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix> 2 proteins, INSRR [</prefix><exact>P14616</exact><postfix>] and MARK2 [Q7KZI7]</postfix><tags><tag><name>P14616</name><uri>http://identifiers.org/uniprot/P14616</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-d9070360224a406b39d8faf27902511b</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation><annotation><prefix>[P14616] and MARK2 [</prefix><exact>Q7KZI7</exact><postfix>], that still have 3</postfix><tags><tag><name>Q7KZI7</name><uri>http://identifiers.org/uniprot/Q7KZI7</uri></tag></tags><id>http://europepmc.org/articles/PMC3086880#europepmc-1f01e3f54257c2242bd9b89c8afe929a</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>UniProt</subType></annotation></annotations></item></List>